|
Resolution: standard / high Figure 1.
Treatment protocol of the BELONG study. AZT, azathioprene; CYC,
cyclophosphamide; EL, EUROLUPUS; LN, lupus nephritis; MMF, mycophenolate mofetil;
OCR, ocrelizumab; ORR, overall renal response; PBO, placebo.
Reddy et al. Arthritis Research & Therapy 2013 15(Suppl 1):S2 doi:10.1186/ar3910 |
